Example: Heart Attack

Search clinical trials for: Dose decrease

Total 7779 results

NCT04034615

Withdrawn

The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars

Cicatrix
NCT01970098

Completed

A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration
NCT01684345

Terminated

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis (EYEGUARD™-A)

Uveitis
NCT02541344

Completed

Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects

Hyperglycemia | Prediabetes
NCT01825811

Completed

Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis

Degenerative Arthritis
NCT00964054

Completed

Depression Outcomes Study of Exercise (DOSE)

Unipolar Depression
NCT00748137

Unknown

Bolus Insulin Card Calculator Randomised Controlled Study

Type 1 Diabetes
NCT06904222

Active, not recruiting

Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older

Respiratory Syncytial Virus Infection
NCT06117657

Not yet recruiting

Safety and Efficacy Clinical Study of KL-HIV-Tri01 in the Treatment of HIV Infected Subjects

HIV Infections
NCT02347176

Completed

Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis (D2213C00001)

Atopic Dermatitis
NCT04875169

Completed

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
NCT07590440

Not yet recruiting

Indian Lung Screening Trial (ILST)

Lung Cancer
NCT07112781

Recruiting

Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate Cancer (FAST-ONE)

Prostate Cancer
NCT06758375

Recruiting

Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients

Multiple Myeloma, Newly Diagnosed
NCT06854679

Recruiting

Dose Escalated Radiotherapy for Rectal Cancers Using MR-guided Radiotherapy (ANDROMEDA)

Rectal Adenocarcinoma
NCT06181929

Recruiting

A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females

Health Risk Behaviors
NCT05854823

Recruiting

The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR

Head and Neck Squamous Cell Carcinoma
NCT05618457

Recruiting

Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory Concentration

Aminoglycoside Dosing Based on PK/PD Characteristics
NCT06845813

Completed

Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD6234

Renal Impairment
NCT05208814

Completed

A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects

Erectile Dysfunction | Pulmonary Arterial Hypertension
NCT05292027

Completed

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
NCT00915122

Completed

Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate

Adenocarcinoma of the Prostate
NCT02467192

Completed

The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the Elderly (PneumOldCT)

Pneumonia
NCT04366661

Enrolling by invitation

Iraqi Trial for Lung Cancer Screening (ITLUCAS)

Lung Cancer
NCT03589313

Completed

Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.

Cystic Fibrosis
NCT02468609

Unknown

Diagnostic Value of Ultralow-dose Computed Tomography for the Detection of Pulmonary Nodules and Lung Parenchym Alterations Compared to Standard-dose CT (RADFL)

Pulmonary Emphysema | Multiple Pulmonary Nodules
NCT01577212

Terminated

Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy (IDEAL-VMAT)

Stage III Non-small Cell Lung Cancer | Individualized Radiation Dose Escalation
NCT00601367

Completed

Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder

Sexual Dysfunctions, Psychological
NCT01427257

Completed

Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
NCT01104844

Withdrawn

Maxi-Analgesic Phase 2 Study to Compare the Analgesic Effects in Different Dosing Groups to Treat Teeth Extraction Pain

Dental Pain
NCT03519659

Active, not recruiting

Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT

PET/CT Imaging
NCT07145229

Recruiting

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Gout Flare | Acute Gouty Arthritis | Gout Flares | Acute Gout Flare
NCT06242470

Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

Melanoma | Sarcoma | Clear Cell Renal Cell Carcinoma | Cervical Cancer | Breast Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer
NCT05109494

Recruiting

Hypofractionated vs Conventional Fractionated RT in Soft Tissue Sarcomas

Soft Tissue Sarcoma
NCT04049591

Recruiting

Higher vs. Lower Dose Heparin for PCI (HD-PCI)

Cardiovascular Diseases | Percutaneous Coronary Intervention
NCT06285916

Completed

A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression (NuMom)

Postpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal Depression
NCT05811442

Completed

Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

Alzheimer's Disease
NCT05047185

Completed

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II (HAE CHAPTER-1)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor Deficiency | C1 Inhibitor Deficiency
NCT06501404

Completed

PREMAPROB. Probiotics to Prevent Necrotizing Enterocolitis

Necrotizing Enterocolitis | Premature Infants
NCT03285438

Completed

REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. (RENOVE)

Venous Thromboembolism
NCT04774809

Terminated

Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

Vitiligo
NCT02691247

Completed

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Diabetes Mellitus
NCT02583373

Completed

Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae

Pneumonia | Pneumococcal Infections
NCT02772289

Completed

Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars

Cicatrix
NCT00889512

Terminated

The Luveris In Vitro Fertilization Trial

Infertility | Hypothalamic Amenorrhea | Hyperprolactinemia
NCT02979158

Completed

Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass

Cardiopulmonary Bypass | Bleeding Disorder | Platelet Dysfunction Due to Drugs | Platelet Disorder
NCT01934205

Completed

To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944

Infections, Bacterial
NCT01747538

Terminated

Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment (EYEGUARD™-C)

Uveitis
NCT02256332

Completed

Plant-based Ingredient on Post Prandial Glucose in Type II Diabetes

Diabetes Mellitus, Type 2
NCT01239069

Completed

Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease

Dry Eye

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations